Comprehensive clinical evaluation of dopriumab in the treatment of moderate to severe atopic dermatitis

doi:10.3969/j.issn.1672-3384.2023.11.014

PDF(486 KB)

Clinical Medication Journal ›› 2023, Vol. 21 ›› Issue (11) : 71-75. DOI: 10.3969/j.issn.1672-3384.2023.11.014

Original Article

Comprehensive clinical evaluation of dopriumab in the treatment of moderate to severe atopic dermatitis

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 21(11): 71-75 https://doi.org/10.3969/j.issn.1672-3384.2023.11.014

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(486 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2023-06-12	2023-11-28
Issue Date
2023-11-28

Please choose a citation manager

Content to export